| Metric | Q1 2022 | Q4 2021 | Q1 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $78M | — | — | — | — |
| Op. Income | $9M | — | — | — | — |
| Gross Margin | 52.9% | — | — | — | — |
| Net Margin | 10.4% | — | — | — | — |
| EPS (Diluted) | $0.55 | — | — | — | — |
| Free Cash Flow | $12M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $78M |
| Cost of Revenue | $37M |
| GROSS PROFIT | $41M |
| R&D Expenses | $8M |
| Selling & Marketing | $7M |
| General & Administrative | $13M |
| SG&A Expenses | $20M |
| Other Expenses | $4M |
| Operating Expenses | $32M |
| Cost & Expenses | $69M |
| OPERATING INCOME | $9M |
| Interest Income | $0 |
| Interest Expense | $917.0K |
| Other Income/Expenses | $490.0K |
| INCOME BEFORE TAX | $9M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $8M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $8M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $8M |
| D&A | $5M |
| EBIT | $10M |
| EBITDA | $15M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $78M |
| Cost of Revenue | $37M |
| GROSS PROFIT | $41M |
| R&D Expenses | $8M |
| Selling & Marketing | $7M |
| General & Administrative | $13M |
| SG&A Expenses | $20M |
| Other Expenses | $4M |
| Operating Expenses | $32M |
| Cost & Expenses | $69M |
| OPERATING INCOME | $9M |
| Interest Income | $0 |
| Interest Expense | $917.0K |
| Other Income/Expenses | $490.0K |
| INCOME BEFORE TAX | $9M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $8M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $8M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $8M |
| D&A | $5M |
| EBIT | $10M |
| EBITDA | $15M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $8M |
| Depreciation & Amortization | $5M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $2M |
| Change in Working Capital | -$5M |
| OPERATING CASH FLOW | $12M |
| Capital Expenditure | -$27.0K |
| Acquisitions (Net) | -$43M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$4M |
| NET CASH FROM INVESTING | -$48M |
| Net Debt Issuance | $42M |
| Common Stock Repurchased | -$2M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $40M |
| FREE CASH FLOW | $12M |
| Net Change in Cash | $5M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $16M |
| Short-Term Investments | $0 |
| Net Receivables | $47M |
| Inventory | $567.0K |
| Other Current Assets | $13M |
| TOTAL CURRENT ASSETS | $81M |
| PP&E (Net) | $20M |
| Goodwill | $198M |
| Intangible Assets | $0 |
| Long-Term Investments | $6M |
| Tax Assets | $131M |
| Other Non-Current Assets | $5M |
| TOTAL NON-CURRENT ASSETS | $360M |
| TOTAL ASSETS | $440M |
| Account Payables | $7M |
| Short-Term Debt | $5M |
| Deferred Revenue | $14M |
| Other Current Liabilities | $4M |
| TOTAL CURRENT LIABILITIES | $47M |
| Long-Term Debt | $137M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $20M |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $163M |
| TOTAL LIABILITIES | $210M |
| Common Stock | $15.0K |
| Additional Paid-In Capital | $189M |
| Retained Earnings | $46M |
| Treasury Stock | -$4M |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $231M |
| Minority Interest | $0 |
| TOTAL EQUITY | $231M |
| TOTAL LIABILITIES & EQUITY | $440M |
| Total Debt | $150M |
| Net Debt | $134M |
